Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Denmark | 71 | 2024 | 771 | 4.870 |
Why?
|
Mendelian Randomization Analysis | 23 | 2024 | 1007 | 4.270 |
Why?
|
Myeloproliferative Disorders | 16 | 2024 | 613 | 3.350 |
Why?
|
Hypothyroidism | 12 | 2024 | 668 | 2.930 |
Why?
|
Transferrin | 12 | 2024 | 283 | 2.880 |
Why?
|
Hemochromatosis | 12 | 2024 | 174 | 2.800 |
Why?
|
Thyroxine | 14 | 2024 | 666 | 2.660 |
Why?
|
Ferritins | 9 | 2024 | 598 | 2.310 |
Why?
|
Milk | 6 | 2018 | 443 | 2.300 |
Why?
|
Lactase | 7 | 2018 | 71 | 2.210 |
Why?
|
Thrombocythemia, Essential | 6 | 2024 | 113 | 2.180 |
Why?
|
Polycythemia Vera | 9 | 2024 | 161 | 2.120 |
Why?
|
Hyperthyroidism | 7 | 2024 | 294 | 2.110 |
Why?
|
Thyroid Gland | 10 | 2024 | 1170 | 2.080 |
Why?
|
Calreticulin | 8 | 2024 | 114 | 2.050 |
Why?
|
Hidradenitis Suppurativa | 14 | 2022 | 178 | 1.860 |
Why?
|
Thyrotropin | 14 | 2024 | 834 | 1.780 |
Why?
|
Janus Kinase 2 | 14 | 2024 | 560 | 1.740 |
Why?
|
Iodide Peroxidase | 7 | 2024 | 294 | 1.550 |
Why?
|
Iron Overload | 8 | 2023 | 239 | 1.430 |
Why?
|
Primary Myelofibrosis | 4 | 2024 | 209 | 1.260 |
Why?
|
Suburban Population | 7 | 2023 | 53 | 1.250 |
Why?
|
Thyroid Hormones | 3 | 2020 | 404 | 1.120 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2024 | 12149 | 1.100 |
Why?
|
Psoriasis | 10 | 2022 | 950 | 1.000 |
Why?
|
Suburban Health | 4 | 2017 | 11 | 0.980 |
Why?
|
Diabetes Mellitus, Type 1 | 12 | 2024 | 3415 | 0.980 |
Why?
|
Iron | 10 | 2024 | 1793 | 0.960 |
Why?
|
Autoantibodies | 6 | 2023 | 2118 | 0.930 |
Why?
|
Lactose Intolerance | 3 | 2018 | 28 | 0.880 |
Why?
|
Acne Vulgaris | 3 | 2018 | 358 | 0.860 |
Why?
|
Strabismus | 3 | 2022 | 317 | 0.850 |
Why?
|
Graves Ophthalmopathy | 2 | 2022 | 133 | 0.850 |
Why?
|
Dairy Products | 4 | 2019 | 490 | 0.840 |
Why?
|
Anemia, Pernicious | 1 | 2022 | 15 | 0.830 |
Why?
|
Wet Macular Degeneration | 1 | 2024 | 162 | 0.780 |
Why?
|
Mortality | 5 | 2024 | 2901 | 0.740 |
Why?
|
Guanosine | 5 | 2024 | 48 | 0.740 |
Why?
|
Oxidative Stress | 11 | 2024 | 3113 | 0.740 |
Why?
|
Electrocardiography | 15 | 2024 | 6377 | 0.720 |
Why?
|
Nucleosides | 1 | 2021 | 131 | 0.710 |
Why?
|
Genotype | 19 | 2024 | 12990 | 0.700 |
Why?
|
Kidney | 7 | 2023 | 7048 | 0.680 |
Why?
|
Birth Weight | 4 | 2021 | 2103 | 0.670 |
Why?
|
Bruch Membrane | 2 | 2016 | 65 | 0.660 |
Why?
|
Sexual Dysfunctions, Psychological | 1 | 2021 | 189 | 0.650 |
Why?
|
Registries | 6 | 2024 | 8224 | 0.650 |
Why?
|
Retinal Drusen | 2 | 2016 | 74 | 0.640 |
Why?
|
Vaginal Birth after Cesarean | 1 | 2019 | 61 | 0.640 |
Why?
|
Goiter | 1 | 2019 | 87 | 0.630 |
Why?
|
Hemostasis | 1 | 2021 | 467 | 0.630 |
Why?
|
Middle Aged | 96 | 2024 | 220917 | 0.620 |
Why?
|
Cross-Sectional Studies | 41 | 2024 | 26127 | 0.620 |
Why?
|
Allostasis | 3 | 2024 | 72 | 0.620 |
Why?
|
Female | 119 | 2024 | 392688 | 0.620 |
Why?
|
Cataract | 1 | 2024 | 832 | 0.610 |
Why?
|
Sex Hormone-Binding Globulin | 1 | 2021 | 550 | 0.610 |
Why?
|
Humans | 176 | 2024 | 761578 | 0.610 |
Why?
|
Prediabetic State | 3 | 2020 | 545 | 0.610 |
Why?
|
Eye Diseases, Hereditary | 2 | 2016 | 122 | 0.600 |
Why?
|
Polymorphism, Single Nucleotide | 13 | 2024 | 15936 | 0.600 |
Why?
|
Aged | 79 | 2024 | 169308 | 0.600 |
Why?
|
Male | 112 | 2024 | 360841 | 0.590 |
Why?
|
Blood Cells | 1 | 2019 | 305 | 0.590 |
Why?
|
Glomerular Filtration Rate | 4 | 2023 | 2178 | 0.580 |
Why?
|
Sexual Dysfunction, Physiological | 1 | 2021 | 357 | 0.570 |
Why?
|
Erectile Dysfunction | 1 | 2021 | 444 | 0.570 |
Why?
|
Appendicitis | 1 | 2024 | 675 | 0.570 |
Why?
|
Macular Degeneration | 1 | 2024 | 1007 | 0.560 |
Why?
|
Abortion, Spontaneous | 2 | 2021 | 533 | 0.540 |
Why?
|
Maternal Age | 1 | 2019 | 809 | 0.540 |
Why?
|
Thyroid Function Tests | 4 | 2021 | 288 | 0.530 |
Why?
|
Adult | 84 | 2024 | 221200 | 0.530 |
Why?
|
Arrhythmias, Cardiac | 5 | 2023 | 2244 | 0.520 |
Why?
|
Genome-Wide Association Study | 16 | 2024 | 12690 | 0.510 |
Why?
|
Aged, 80 and over | 37 | 2024 | 58983 | 0.510 |
Why?
|
Triiodothyronine | 6 | 2024 | 493 | 0.510 |
Why?
|
Smoking | 5 | 2019 | 9053 | 0.490 |
Why?
|
Disease Susceptibility | 2 | 2020 | 1787 | 0.490 |
Why?
|
Biological Specimen Banks | 4 | 2024 | 783 | 0.490 |
Why?
|
Arthritis, Psoriatic | 1 | 2017 | 219 | 0.480 |
Why?
|
Population Surveillance | 5 | 2019 | 2598 | 0.480 |
Why?
|
Spirometry | 1 | 2018 | 929 | 0.480 |
Why?
|
Inflammation | 10 | 2024 | 10774 | 0.470 |
Why?
|
RNA | 6 | 2024 | 2725 | 0.460 |
Why?
|
Hip Fractures | 3 | 2018 | 988 | 0.460 |
Why?
|
Depressive Disorder | 3 | 2022 | 3728 | 0.460 |
Why?
|
Iron, Dietary | 4 | 2023 | 148 | 0.450 |
Why?
|
Risk Factors | 33 | 2024 | 74212 | 0.450 |
Why?
|
Specimen Handling | 2 | 2016 | 702 | 0.450 |
Why?
|
beta-Thalassemia | 1 | 2016 | 236 | 0.440 |
Why?
|
Chemistry, Clinical | 3 | 2022 | 64 | 0.440 |
Why?
|
Educational Status | 3 | 2017 | 2522 | 0.430 |
Why?
|
Thyroidectomy | 1 | 2019 | 908 | 0.430 |
Why?
|
Genetic Predisposition to Disease | 13 | 2023 | 17904 | 0.420 |
Why?
|
Interferon-alpha | 5 | 2024 | 921 | 0.420 |
Why?
|
Laparoscopy | 1 | 2024 | 2036 | 0.400 |
Why?
|
Creatinine | 5 | 2023 | 1899 | 0.400 |
Why?
|
Prenatal Care | 1 | 2019 | 1139 | 0.390 |
Why?
|
Metabolic Diseases | 1 | 2018 | 683 | 0.390 |
Why?
|
Case-Control Studies | 25 | 2023 | 22176 | 0.390 |
Why?
|
Young Adult | 38 | 2024 | 59254 | 0.390 |
Why?
|
Immunity, Cellular | 1 | 2017 | 1560 | 0.390 |
Why?
|
Atrial Fibrillation | 3 | 2019 | 5127 | 0.390 |
Why?
|
Self Report | 6 | 2024 | 3725 | 0.380 |
Why?
|
Goals | 1 | 2017 | 711 | 0.380 |
Why?
|
Long QT Syndrome | 1 | 2016 | 467 | 0.380 |
Why?
|
Kidney Diseases | 2 | 2020 | 2091 | 0.380 |
Why?
|
Social Class | 2 | 2017 | 2004 | 0.370 |
Why?
|
Maternal Exposure | 1 | 2018 | 1067 | 0.370 |
Why?
|
Th17 Cells | 1 | 2017 | 794 | 0.370 |
Why?
|
Mutation | 15 | 2024 | 30054 | 0.350 |
Why?
|
Myocardial Ischemia | 2 | 2015 | 2113 | 0.350 |
Why?
|
Lymphocytes | 3 | 2024 | 2612 | 0.340 |
Why?
|
Albuminuria | 3 | 2023 | 658 | 0.340 |
Why?
|
Genetic Association Studies | 1 | 2019 | 2735 | 0.340 |
Why?
|
Personal Satisfaction | 1 | 2014 | 644 | 0.340 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2018 | 851 | 0.340 |
Why?
|
Rural Population | 6 | 2020 | 2285 | 0.310 |
Why?
|
Hypertension | 7 | 2020 | 8540 | 0.310 |
Why?
|
Diabetes Mellitus | 7 | 2020 | 5841 | 0.310 |
Why?
|
Biological Products | 1 | 2017 | 914 | 0.310 |
Why?
|
Antidepressive Agents | 3 | 2022 | 2897 | 0.310 |
Why?
|
Diabetes, Gestational | 1 | 2018 | 1248 | 0.300 |
Why?
|
Income | 1 | 2017 | 1877 | 0.300 |
Why?
|
Bone Density | 2 | 2018 | 3551 | 0.300 |
Why?
|
Cardiovascular Diseases | 10 | 2023 | 15502 | 0.300 |
Why?
|
Antirheumatic Agents | 1 | 2017 | 1373 | 0.300 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2022 | 2242 | 0.290 |
Why?
|
Rural Health | 2 | 2020 | 296 | 0.290 |
Why?
|
Phenotype | 3 | 2021 | 16592 | 0.290 |
Why?
|
Life Style | 2 | 2017 | 3917 | 0.280 |
Why?
|
Adipokines | 2 | 2019 | 310 | 0.280 |
Why?
|
Hydroxyurea | 3 | 2023 | 284 | 0.280 |
Why?
|
Polyethylene Glycols | 2 | 2024 | 1189 | 0.270 |
Why?
|
Early Detection of Cancer | 1 | 2021 | 3201 | 0.270 |
Why?
|
Heart Conduction System | 3 | 2022 | 1007 | 0.270 |
Why?
|
Health Surveys | 4 | 2018 | 4061 | 0.270 |
Why?
|
General Practice | 2 | 2017 | 97 | 0.270 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2015 | 1081 | 0.260 |
Why?
|
Vision Screening | 2 | 2019 | 72 | 0.260 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2018 | 2518 | 0.260 |
Why?
|
Deoxyguanosine | 3 | 2024 | 93 | 0.260 |
Why?
|
Prevalence | 13 | 2020 | 15732 | 0.260 |
Why?
|
Body Mass Index | 7 | 2022 | 12953 | 0.250 |
Why?
|
Urban Population | 1 | 2013 | 2036 | 0.250 |
Why?
|
Genetic Variation | 3 | 2019 | 6567 | 0.240 |
Why?
|
Gene Frequency | 3 | 2023 | 3606 | 0.240 |
Why?
|
Depression | 3 | 2018 | 8124 | 0.240 |
Why?
|
Age Factors | 11 | 2019 | 18398 | 0.240 |
Why?
|
Visually Impaired Persons | 2 | 2016 | 78 | 0.240 |
Why?
|
Socioeconomic Factors | 2 | 2017 | 7827 | 0.230 |
Why?
|
Neoplasms | 9 | 2023 | 22172 | 0.230 |
Why?
|
Antihypertensive Agents | 4 | 2017 | 2024 | 0.230 |
Why?
|
Depressive Disorder, Major | 4 | 2021 | 4761 | 0.230 |
Why?
|
Overweight | 1 | 2015 | 2417 | 0.230 |
Why?
|
Netherlands | 3 | 2018 | 2221 | 0.230 |
Why?
|
Isocarboxazid | 1 | 2003 | 7 | 0.220 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2018 | 3246 | 0.220 |
Why?
|
Obesity | 5 | 2022 | 12947 | 0.220 |
Why?
|
Somatotypes | 1 | 2023 | 41 | 0.210 |
Why?
|
Heart Rate | 6 | 2024 | 4195 | 0.210 |
Why?
|
Blood Pressure | 5 | 2020 | 8481 | 0.210 |
Why?
|
Disease Progression | 4 | 2022 | 13510 | 0.210 |
Why?
|
Follow-Up Studies | 9 | 2024 | 39107 | 0.210 |
Why?
|
Blood Coagulation | 2 | 2021 | 1154 | 0.200 |
Why?
|
Asthma | 2 | 2023 | 6234 | 0.200 |
Why?
|
Myocardial Infarction | 5 | 2022 | 11461 | 0.200 |
Why?
|
Vascular Diseases | 2 | 2021 | 1161 | 0.200 |
Why?
|
Atrioventricular Node | 1 | 2022 | 180 | 0.200 |
Why?
|
Nitriles | 2 | 2024 | 971 | 0.190 |
Why?
|
Dementia, Vascular | 1 | 2022 | 122 | 0.190 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2017 | 10212 | 0.190 |
Why?
|
Alleles | 5 | 2020 | 6864 | 0.190 |
Why?
|
DNA Damage | 4 | 2024 | 2449 | 0.190 |
Why?
|
Antithyroid Agents | 1 | 2021 | 72 | 0.190 |
Why?
|
Atrioventricular Block | 1 | 2023 | 133 | 0.190 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3358 | 0.190 |
Why?
|
Incidence | 6 | 2024 | 21355 | 0.190 |
Why?
|
Liver Diseases | 2 | 2007 | 1297 | 0.190 |
Why?
|
Janus Kinase 1 | 1 | 2021 | 107 | 0.180 |
Why?
|
Platelet Activation | 1 | 2024 | 645 | 0.180 |
Why?
|
Interferons | 2 | 2022 | 706 | 0.180 |
Why?
|
Odds Ratio | 7 | 2019 | 9646 | 0.180 |
Why?
|
Appendectomy | 1 | 2024 | 433 | 0.180 |
Why?
|
Blood Coagulation Tests | 1 | 2021 | 271 | 0.180 |
Why?
|
Cholesterol, HDL | 5 | 2024 | 1814 | 0.170 |
Why?
|
Fibrinolysis | 1 | 2021 | 332 | 0.170 |
Why?
|
Fathers | 1 | 2023 | 376 | 0.170 |
Why?
|
Methylenetetrahydrofolate Reductase (NADPH2) | 1 | 2021 | 276 | 0.170 |
Why?
|
Sleep | 1 | 2015 | 4768 | 0.170 |
Why?
|
Oxidation-Reduction | 4 | 2018 | 2231 | 0.170 |
Why?
|
Megakaryocytes | 1 | 2024 | 567 | 0.170 |
Why?
|
Biomedical Research | 1 | 2015 | 3429 | 0.170 |
Why?
|
Lung | 1 | 2018 | 10002 | 0.170 |
Why?
|
Albumins | 1 | 2022 | 575 | 0.160 |
Why?
|
Proportional Hazards Models | 6 | 2024 | 12463 | 0.160 |
Why?
|
Blood Coagulation Factors | 1 | 2021 | 365 | 0.160 |
Why?
|
Erythrocyte Count | 1 | 2019 | 157 | 0.160 |
Why?
|
Pregnancy | 6 | 2021 | 29876 | 0.160 |
Why?
|
Thyroiditis, Autoimmune | 1 | 2019 | 101 | 0.160 |
Why?
|
Prospective Studies | 15 | 2024 | 54423 | 0.160 |
Why?
|
Erythropoiesis | 1 | 2022 | 683 | 0.150 |
Why?
|
Atrial Premature Complexes | 1 | 2018 | 17 | 0.150 |
Why?
|
Insulin-Secreting Cells | 2 | 2016 | 901 | 0.150 |
Why?
|
Blood Platelets | 3 | 2024 | 2479 | 0.150 |
Why?
|
Cohort Studies | 9 | 2024 | 41493 | 0.150 |
Why?
|
Mannose-Binding Lectin | 1 | 2019 | 145 | 0.150 |
Why?
|
Ankle Brachial Index | 1 | 2018 | 163 | 0.150 |
Why?
|
Glaucoma, Open-Angle | 1 | 2024 | 738 | 0.150 |
Why?
|
Homocysteine | 1 | 2021 | 638 | 0.150 |
Why?
|
Leukocyte Count | 2 | 2019 | 1596 | 0.150 |
Why?
|
Risk | 6 | 2024 | 9610 | 0.150 |
Why?
|
Neutrophils | 2 | 2024 | 3767 | 0.150 |
Why?
|
Kidney Function Tests | 1 | 2020 | 679 | 0.150 |
Why?
|
Risk Assessment | 8 | 2021 | 23996 | 0.140 |
Why?
|
von Willebrand Factor | 1 | 2021 | 673 | 0.140 |
Why?
|
Genetic Testing | 4 | 2022 | 3537 | 0.140 |
Why?
|
Coronary Artery Disease | 3 | 2023 | 6403 | 0.140 |
Why?
|
Recombinant Proteins | 2 | 2024 | 6534 | 0.140 |
Why?
|
Histocompatibility Antigens Class I | 4 | 2024 | 1349 | 0.140 |
Why?
|
Decompression, Surgical | 1 | 2022 | 607 | 0.140 |
Why?
|
Membrane Proteins | 5 | 2024 | 7859 | 0.140 |
Why?
|
Poverty Areas | 1 | 2018 | 263 | 0.140 |
Why?
|
Thyroid Diseases | 1 | 2020 | 386 | 0.140 |
Why?
|
Gonadal Steroid Hormones | 1 | 2021 | 702 | 0.140 |
Why?
|
Ventricular Premature Complexes | 1 | 2018 | 112 | 0.140 |
Why?
|
Tumor Escape | 1 | 2020 | 370 | 0.140 |
Why?
|
Islets of Langerhans | 1 | 2023 | 1341 | 0.140 |
Why?
|
Lymphocyte Count | 1 | 2019 | 778 | 0.140 |
Why?
|
Receptors, Transferrin | 1 | 2018 | 291 | 0.140 |
Why?
|
Pyrazoles | 2 | 2024 | 2009 | 0.140 |
Why?
|
Athletic Performance | 1 | 2017 | 111 | 0.140 |
Why?
|
Quality of Life | 3 | 2020 | 13367 | 0.130 |
Why?
|
Comorbidity | 6 | 2023 | 10508 | 0.130 |
Why?
|
Stroke | 3 | 2022 | 9758 | 0.130 |
Why?
|
Skin Diseases | 2 | 2016 | 1094 | 0.130 |
Why?
|
Electrophysiologic Techniques, Cardiac | 1 | 2019 | 506 | 0.130 |
Why?
|
Superoxide Dismutase | 1 | 2019 | 594 | 0.130 |
Why?
|
Fertility | 1 | 2021 | 771 | 0.130 |
Why?
|
Retrospective Studies | 10 | 2024 | 80646 | 0.130 |
Why?
|
Drug Utilization | 2 | 2014 | 1188 | 0.130 |
Why?
|
Immunomodulation | 1 | 2020 | 549 | 0.130 |
Why?
|
Magnesium | 1 | 2019 | 804 | 0.130 |
Why?
|
Complement C3 | 1 | 2017 | 435 | 0.130 |
Why?
|
Models, Cardiovascular | 1 | 2021 | 981 | 0.130 |
Why?
|
Longitudinal Studies | 3 | 2024 | 14607 | 0.130 |
Why?
|
Fever | 1 | 2003 | 1618 | 0.120 |
Why?
|
Clinical Laboratory Techniques | 1 | 2021 | 746 | 0.120 |
Why?
|
Vital Capacity | 1 | 2018 | 971 | 0.120 |
Why?
|
Interleukin-1 | 1 | 2019 | 1248 | 0.120 |
Why?
|
Diabetic Retinopathy | 1 | 2024 | 1274 | 0.120 |
Why?
|
Zinc | 1 | 2019 | 690 | 0.120 |
Why?
|
Cholesterol, LDL | 4 | 2022 | 2382 | 0.120 |
Why?
|
Potassium | 1 | 2019 | 1311 | 0.120 |
Why?
|
Physical Endurance | 1 | 2017 | 366 | 0.120 |
Why?
|
Pyrimidines | 2 | 2024 | 3028 | 0.120 |
Why?
|
Amino Acid Substitution | 1 | 2019 | 1739 | 0.120 |
Why?
|
C-Reactive Protein | 4 | 2022 | 3826 | 0.120 |
Why?
|
Glucocorticoids | 1 | 2024 | 2161 | 0.120 |
Why?
|
Mood Disorders | 1 | 2021 | 1127 | 0.120 |
Why?
|
Heart Failure | 1 | 2018 | 11671 | 0.120 |
Why?
|
Diet | 4 | 2019 | 8075 | 0.120 |
Why?
|
Cytokines | 2 | 2019 | 7396 | 0.110 |
Why?
|
Folic Acid | 1 | 2021 | 1323 | 0.110 |
Why?
|
Sex Factors | 6 | 2019 | 10554 | 0.110 |
Why?
|
5' Untranslated Regions | 1 | 2015 | 256 | 0.110 |
Why?
|
Psychiatric Status Rating Scales | 2 | 2014 | 6019 | 0.110 |
Why?
|
Medicine | 1 | 2022 | 942 | 0.110 |
Why?
|
Waist Circumference | 1 | 2017 | 935 | 0.110 |
Why?
|
Estradiol | 1 | 2021 | 1937 | 0.110 |
Why?
|
Urine | 1 | 2015 | 362 | 0.110 |
Why?
|
Outpatient Clinics, Hospital | 1 | 2016 | 395 | 0.110 |
Why?
|
Infant, Newborn, Diseases | 1 | 2019 | 589 | 0.110 |
Why?
|
Brain Ischemia | 1 | 2007 | 3049 | 0.110 |
Why?
|
Angina Pectoris | 1 | 2017 | 959 | 0.110 |
Why?
|
Area Under Curve | 1 | 2017 | 1638 | 0.110 |
Why?
|
Severity of Illness Index | 8 | 2019 | 15843 | 0.110 |
Why?
|
Gallstones | 1 | 2015 | 284 | 0.110 |
Why?
|
Random Allocation | 1 | 2017 | 2395 | 0.110 |
Why?
|
Forced Expiratory Volume | 1 | 2018 | 1814 | 0.110 |
Why?
|
Physical Fitness | 1 | 2017 | 743 | 0.110 |
Why?
|
Infant, Newborn | 7 | 2024 | 26198 | 0.110 |
Why?
|
Exons | 1 | 2019 | 2391 | 0.100 |
Why?
|
Age Distribution | 4 | 2014 | 2879 | 0.100 |
Why?
|
Demography | 1 | 2017 | 1648 | 0.100 |
Why?
|
Epidemics | 1 | 2018 | 512 | 0.100 |
Why?
|
Genetics, Population | 1 | 2017 | 937 | 0.100 |
Why?
|
Amblyopia | 1 | 2014 | 150 | 0.100 |
Why?
|
Blood | 1 | 2015 | 596 | 0.100 |
Why?
|
Microcirculation | 1 | 2017 | 1272 | 0.100 |
Why?
|
Thrombophilia | 1 | 2015 | 305 | 0.100 |
Why?
|
Health Services Research | 1 | 2020 | 1812 | 0.100 |
Why?
|
Self Care | 1 | 2017 | 796 | 0.100 |
Why?
|
Quality Control | 1 | 2015 | 832 | 0.100 |
Why?
|
Photography | 1 | 2015 | 532 | 0.100 |
Why?
|
Genetic Linkage | 1 | 2017 | 2341 | 0.100 |
Why?
|
Hemoglobins | 1 | 2018 | 1526 | 0.100 |
Why?
|
Immunologic Memory | 1 | 2019 | 1359 | 0.100 |
Why?
|
Autoimmunity | 2 | 2023 | 1356 | 0.100 |
Why?
|
Liver Neoplasms | 1 | 2007 | 4317 | 0.100 |
Why?
|
Epidemiologic Studies | 1 | 2015 | 675 | 0.100 |
Why?
|
Animals | 10 | 2021 | 168475 | 0.100 |
Why?
|
Mental Disorders | 2 | 2024 | 6845 | 0.100 |
Why?
|
Dietary Fats | 1 | 2019 | 1995 | 0.090 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2013 | 422 | 0.090 |
Why?
|
Research Design | 3 | 2017 | 6180 | 0.090 |
Why?
|
Coronary Circulation | 1 | 2017 | 1569 | 0.090 |
Why?
|
Spinal Fractures | 1 | 2018 | 705 | 0.090 |
Why?
|
Sports | 1 | 2017 | 705 | 0.090 |
Why?
|
Triglycerides | 2 | 2022 | 2461 | 0.090 |
Why?
|
Adolescent | 10 | 2024 | 88323 | 0.090 |
Why?
|
Personality Inventory | 1 | 2014 | 1019 | 0.090 |
Why?
|
Cost of Illness | 1 | 2020 | 1936 | 0.090 |
Why?
|
Health Status | 1 | 2024 | 4077 | 0.090 |
Why?
|
Fluorescein Angiography | 1 | 2016 | 1059 | 0.090 |
Why?
|
Gestational Age | 1 | 2019 | 3577 | 0.090 |
Why?
|
Saliva | 1 | 2015 | 828 | 0.090 |
Why?
|
Length of Stay | 1 | 2024 | 6426 | 0.090 |
Why?
|
Testosterone | 1 | 2021 | 2472 | 0.090 |
Why?
|
Aortic Valve Stenosis | 1 | 2022 | 2001 | 0.080 |
Why?
|
Anticholesteremic Agents | 1 | 2017 | 966 | 0.080 |
Why?
|
Nutritional Status | 1 | 2018 | 1615 | 0.080 |
Why?
|
ROC Curve | 1 | 2017 | 3578 | 0.080 |
Why?
|
Alzheimer Disease | 2 | 2021 | 8601 | 0.080 |
Why?
|
Anti-Inflammatory Agents | 1 | 2019 | 1809 | 0.080 |
Why?
|
Infertility, Female | 1 | 2015 | 760 | 0.080 |
Why?
|
Metalloendopeptidases | 2 | 2002 | 393 | 0.080 |
Why?
|
Statistics as Topic | 1 | 2015 | 2358 | 0.080 |
Why?
|
Pregnancy Outcome | 1 | 2019 | 2922 | 0.080 |
Why?
|
Anthropometry | 1 | 2013 | 1349 | 0.080 |
Why?
|
International Classification of Diseases | 1 | 2014 | 909 | 0.080 |
Why?
|
Lumbar Vertebrae | 1 | 2018 | 1879 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 2 | 2020 | 6484 | 0.080 |
Why?
|
Vision Disorders | 1 | 2016 | 1088 | 0.080 |
Why?
|
Lipids | 1 | 2019 | 3341 | 0.080 |
Why?
|
Insulin | 3 | 2019 | 6597 | 0.080 |
Why?
|
Leukocytes | 1 | 2016 | 2026 | 0.080 |
Why?
|
Dietary Supplements | 2 | 2018 | 3415 | 0.070 |
Why?
|
Hematologic Neoplasms | 1 | 2020 | 1896 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2019 | 2226 | 0.070 |
Why?
|
Patient-Centered Care | 1 | 2017 | 1421 | 0.070 |
Why?
|
Sensitivity and Specificity | 2 | 2024 | 14665 | 0.070 |
Why?
|
Physical Examination | 1 | 2013 | 1255 | 0.070 |
Why?
|
Multivariate Analysis | 3 | 2020 | 12059 | 0.070 |
Why?
|
Predictive Value of Tests | 2 | 2017 | 15266 | 0.070 |
Why?
|
Clinical Trials as Topic | 3 | 2021 | 8002 | 0.070 |
Why?
|
Dermatitis, Atopic | 1 | 2014 | 731 | 0.070 |
Why?
|
Peripheral Arterial Disease | 1 | 2018 | 1273 | 0.070 |
Why?
|
Body Composition | 1 | 2015 | 2426 | 0.070 |
Why?
|
Calcium | 1 | 2019 | 5722 | 0.070 |
Why?
|
Anemia | 1 | 2015 | 1509 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3303 | 0.060 |
Why?
|
Asymptomatic Diseases | 2 | 2019 | 588 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2017 | 3575 | 0.060 |
Why?
|
Pharmacogenetics | 1 | 2009 | 675 | 0.060 |
Why?
|
Insulin Resistance | 2 | 2016 | 3964 | 0.060 |
Why?
|
Heart | 1 | 2018 | 4404 | 0.060 |
Why?
|
Feeding Behavior | 1 | 2017 | 3188 | 0.060 |
Why?
|
Endpoint Determination | 1 | 2007 | 590 | 0.060 |
Why?
|
Protein Kinase Inhibitors | 1 | 2021 | 5672 | 0.060 |
Why?
|
Homozygote | 2 | 2007 | 1776 | 0.060 |
Why?
|
Retina | 1 | 2015 | 2659 | 0.060 |
Why?
|
Stroke Volume | 1 | 2018 | 5496 | 0.060 |
Why?
|
Hydrocortisone | 2 | 2022 | 1819 | 0.060 |
Why?
|
Hypoglycemic Agents | 1 | 2017 | 3085 | 0.060 |
Why?
|
Hospitals | 2 | 2015 | 3882 | 0.060 |
Why?
|
Evidence-Based Medicine | 1 | 2016 | 3688 | 0.060 |
Why?
|
Child | 6 | 2024 | 80157 | 0.050 |
Why?
|
Motor Activity | 1 | 2013 | 2715 | 0.050 |
Why?
|
Mass Screening | 1 | 2019 | 5428 | 0.050 |
Why?
|
Autoimmune Diseases | 1 | 2015 | 2244 | 0.050 |
Why?
|
Molecular Epidemiology | 1 | 2005 | 469 | 0.050 |
Why?
|
Heterozygote | 2 | 2007 | 2787 | 0.050 |
Why?
|
Prognosis | 2 | 2021 | 29629 | 0.050 |
Why?
|
Colon | 2 | 2002 | 1792 | 0.050 |
Why?
|
Estrogen Receptor alpha | 1 | 2007 | 583 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3407 | 0.050 |
Why?
|
Venous Thromboembolism | 1 | 2015 | 1866 | 0.050 |
Why?
|
Reference Values | 3 | 2021 | 4920 | 0.050 |
Why?
|
Confidence Intervals | 2 | 2021 | 2927 | 0.050 |
Why?
|
Defense Mechanisms | 1 | 2022 | 180 | 0.050 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4853 | 0.050 |
Why?
|
Sex Determination Analysis | 1 | 2021 | 47 | 0.050 |
Why?
|
Postoperative Complications | 1 | 2024 | 15633 | 0.050 |
Why?
|
Cities | 1 | 2024 | 546 | 0.050 |
Why?
|
T-Lymphocytes | 1 | 2019 | 10194 | 0.050 |
Why?
|
Cardiac Surgical Procedures | 1 | 2016 | 3627 | 0.050 |
Why?
|
Elastin | 1 | 2022 | 298 | 0.050 |
Why?
|
Histamine | 1 | 2022 | 499 | 0.050 |
Why?
|
Blood Cell Count | 1 | 2021 | 397 | 0.040 |
Why?
|
Carotid Artery Diseases | 1 | 2007 | 877 | 0.040 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4028 | 0.040 |
Why?
|
Family Health | 1 | 2005 | 1257 | 0.040 |
Why?
|
Heart Defects, Congenital | 1 | 2016 | 4671 | 0.040 |
Why?
|
Intestinal Mucosa | 2 | 2002 | 3032 | 0.040 |
Why?
|
Analysis of Variance | 2 | 2014 | 6228 | 0.040 |
Why?
|
Privacy | 1 | 2021 | 233 | 0.040 |
Why?
|
Anesthesia, Local | 1 | 2021 | 277 | 0.040 |
Why?
|
T-Cell Antigen Receptor Specificity | 1 | 2019 | 85 | 0.040 |
Why?
|
DNA | 2 | 2023 | 7213 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2022 | 654 | 0.040 |
Why?
|
Tibial Arteries | 1 | 2018 | 60 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4111 | 0.040 |
Why?
|
Laboratories | 1 | 2022 | 458 | 0.040 |
Why?
|
Ophthalmologic Surgical Procedures | 1 | 2021 | 354 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2022 | 973 | 0.040 |
Why?
|
Genomic Instability | 1 | 2022 | 709 | 0.040 |
Why?
|
Arteries | 1 | 2022 | 1123 | 0.040 |
Why?
|
Oculomotor Muscles | 1 | 2021 | 406 | 0.040 |
Why?
|
Competitive Behavior | 1 | 2017 | 78 | 0.040 |
Why?
|
Brachial Artery | 1 | 2018 | 366 | 0.030 |
Why?
|
Cicatrix | 1 | 2022 | 798 | 0.030 |
Why?
|
Water Supply | 1 | 2017 | 204 | 0.030 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2021 | 710 | 0.030 |
Why?
|
Infant | 3 | 2024 | 36193 | 0.030 |
Why?
|
Protease Inhibitors | 1 | 1999 | 754 | 0.030 |
Why?
|
Visual Acuity | 2 | 2016 | 2672 | 0.030 |
Why?
|
Immunity, Innate | 2 | 2019 | 3066 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 870 | 0.030 |
Why?
|
Treatment Outcome | 4 | 2024 | 64684 | 0.030 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 828 | 0.030 |
Why?
|
Neonatal Screening | 1 | 2019 | 597 | 0.030 |
Why?
|
Partial Thromboplastin Time | 1 | 2015 | 204 | 0.030 |
Why?
|
Autopsy | 1 | 2018 | 1009 | 0.030 |
Why?
|
Suppuration | 1 | 2014 | 60 | 0.030 |
Why?
|
Unemployment | 1 | 2016 | 210 | 0.030 |
Why?
|
Teaching | 1 | 2022 | 1170 | 0.030 |
Why?
|
Antioxidants | 1 | 2022 | 1668 | 0.030 |
Why?
|
Death, Sudden, Cardiac | 1 | 2022 | 1555 | 0.030 |
Why?
|
Suicide, Attempted | 1 | 2003 | 1402 | 0.030 |
Why?
|
Hand Dermatoses | 1 | 2014 | 62 | 0.030 |
Why?
|
Bilirubin | 1 | 2015 | 436 | 0.030 |
Why?
|
Fundus Oculi | 1 | 2015 | 556 | 0.030 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2022 | 4352 | 0.030 |
Why?
|
Calcinosis | 1 | 2022 | 1469 | 0.030 |
Why?
|
Nitric Oxide | 1 | 2022 | 2135 | 0.030 |
Why?
|
International Normalized Ratio | 1 | 2015 | 382 | 0.030 |
Why?
|
Logistic Models | 2 | 2018 | 13255 | 0.030 |
Why?
|
Family Characteristics | 1 | 2018 | 1004 | 0.030 |
Why?
|
Epitopes | 1 | 2020 | 2503 | 0.030 |
Why?
|
China | 1 | 2019 | 2374 | 0.030 |
Why?
|
Microvessels | 1 | 2017 | 577 | 0.030 |
Why?
|
Diabetic Angiopathies | 1 | 2018 | 803 | 0.030 |
Why?
|
Alanine Transaminase | 1 | 2015 | 603 | 0.030 |
Why?
|
Sickness Impact Profile | 1 | 2014 | 299 | 0.030 |
Why?
|
Immunity | 1 | 2019 | 996 | 0.030 |
Why?
|
Pruritus | 1 | 2016 | 380 | 0.030 |
Why?
|
Chronic Disease | 2 | 2020 | 9319 | 0.030 |
Why?
|
Bipolar Disorder | 2 | 2021 | 5092 | 0.030 |
Why?
|
Platelet Count | 1 | 2015 | 781 | 0.030 |
Why?
|
Alkaline Phosphatase | 1 | 2015 | 864 | 0.030 |
Why?
|
Serum Albumin | 1 | 2015 | 672 | 0.030 |
Why?
|
Blood Glucose | 2 | 2019 | 6391 | 0.030 |
Why?
|
Aortic Valve | 1 | 2022 | 1955 | 0.030 |
Why?
|
Antigens, Neoplasm | 1 | 2020 | 1993 | 0.020 |
Why?
|
Diet, Mediterranean | 1 | 2018 | 740 | 0.020 |
Why?
|
Hypertriglyceridemia | 1 | 2014 | 293 | 0.020 |
Why?
|
Obesity, Abdominal | 1 | 2014 | 374 | 0.020 |
Why?
|
Eczema | 1 | 2014 | 246 | 0.020 |
Why?
|
Adaptive Immunity | 1 | 2016 | 726 | 0.020 |
Why?
|
Central Nervous System | 1 | 2018 | 1336 | 0.020 |
Why?
|
Energy Intake | 1 | 2018 | 2134 | 0.020 |
Why?
|
Hypothalamus | 1 | 2016 | 999 | 0.020 |
Why?
|
Adaptation, Physiological | 1 | 2017 | 1301 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5872 | 0.020 |
Why?
|
Colitis, Ulcerative | 1 | 2002 | 1922 | 0.020 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2020 | 2827 | 0.020 |
Why?
|
Lower Extremity | 1 | 2018 | 1202 | 0.020 |
Why?
|
Crohn Disease | 1 | 2002 | 2279 | 0.020 |
Why?
|
Neoplastic Stem Cells | 1 | 2017 | 1351 | 0.020 |
Why?
|
ADAM Proteins | 2 | 2002 | 238 | 0.020 |
Why?
|
Regression Analysis | 1 | 2019 | 6344 | 0.020 |
Why?
|
Observer Variation | 1 | 2015 | 2606 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2019 | 3208 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2280 | 0.020 |
Why?
|
Child, Preschool | 2 | 2024 | 42231 | 0.020 |
Why?
|
Fasting | 1 | 2014 | 1603 | 0.020 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2022 | 4580 | 0.020 |
Why?
|
Heart Diseases | 1 | 2021 | 2781 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2140 | 0.020 |
Why?
|
Computer Simulation | 1 | 2021 | 6241 | 0.020 |
Why?
|
Thrombocytopenia | 1 | 2015 | 1182 | 0.020 |
Why?
|
Dyslipidemias | 1 | 2014 | 868 | 0.020 |
Why?
|
Disease | 1 | 2012 | 672 | 0.020 |
Why?
|
Pain | 1 | 2021 | 5073 | 0.020 |
Why?
|
Genomics | 1 | 2022 | 5821 | 0.020 |
Why?
|
Reproducibility of Results | 1 | 2024 | 20099 | 0.020 |
Why?
|
Time Factors | 2 | 2020 | 39970 | 0.020 |
Why?
|
Homeostasis | 1 | 2016 | 3323 | 0.020 |
Why?
|
Inflammatory Bowel Diseases | 1 | 1999 | 2422 | 0.010 |
Why?
|
Aging | 1 | 2023 | 8711 | 0.010 |
Why?
|
Breast Neoplasms | 2 | 2008 | 21019 | 0.010 |
Why?
|
Adaptation, Psychological | 1 | 2014 | 2629 | 0.010 |
Why?
|
BRCA2 Protein | 1 | 2008 | 805 | 0.010 |
Why?
|
Apoptosis Regulatory Proteins | 1 | 2008 | 1136 | 0.010 |
Why?
|
Skin | 1 | 2016 | 4484 | 0.010 |
Why?
|
Lipoproteins, HDL | 1 | 2007 | 676 | 0.010 |
Why?
|
Pulmonary Embolism | 1 | 2015 | 2567 | 0.010 |
Why?
|
Exercise | 1 | 2018 | 5890 | 0.010 |
Why?
|
Genital Neoplasms, Female | 1 | 2007 | 532 | 0.010 |
Why?
|
Recurrence | 1 | 2014 | 8466 | 0.010 |
Why?
|
BRCA1 Protein | 1 | 2008 | 1158 | 0.010 |
Why?
|
Algorithms | 1 | 2021 | 14032 | 0.010 |
Why?
|
Disease Models, Animal | 1 | 2020 | 18255 | 0.010 |
Why?
|
Estrogen Replacement Therapy | 1 | 2007 | 1208 | 0.010 |
Why?
|
Apoptosis | 1 | 2016 | 9491 | 0.010 |
Why?
|
Schizophrenia | 1 | 2018 | 6937 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2017 | 22173 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13642 | 0.010 |
Why?
|
HLA Antigens | 1 | 2002 | 1328 | 0.010 |
Why?
|
Polymorphism, Genetic | 1 | 2007 | 4243 | 0.010 |
Why?
|
Oligopeptides | 1 | 1999 | 1187 | 0.010 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 1999 | 4576 | 0.010 |
Why?
|
United States | 1 | 2019 | 72335 | 0.010 |
Why?
|
Colonoscopy | 1 | 1999 | 1394 | 0.010 |
Why?
|
Mice | 1 | 2017 | 81539 | 0.010 |
Why?
|
Cell Membrane | 1 | 1999 | 3687 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2002 | 11076 | 0.000 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 13446 | 0.000 |
Why?
|
Biopsy | 1 | 1999 | 6766 | 0.000 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 17635 | 0.000 |
Why?
|
RNA, Messenger | 1 | 1999 | 12794 | 0.000 |
Why?
|
Prostatic Neoplasms | 1 | 2007 | 11122 | 0.000 |
Why?
|